Molecular Pathogenesis of Peripheral T Cell Lymphoma.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 429, doi. 10.1007/s11899-015-0289-7
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2015 AND VI 10 AND IP 4
Results: 16
1
2
Targets, Toxins, and T Cells-a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 438, doi. 10.1007/s11899-015-0290-1
- By:
- Publication type:
- Article
3
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 448, doi. 10.1007/s11899-015-0291-0
- By:
- Publication type:
- Article
4
Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 335, doi. 10.1007/s11899-015-0278-x
- By:
- Publication type:
- Article
5
Current Challenges in Stem Cell Transplantation in Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 344, doi. 10.1007/s11899-015-0279-9
- By:
- Publication type:
- Article
6
Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 351, doi. 10.1007/s11899-015-0280-3
- By:
- Publication type:
- Article
7
Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 362, doi. 10.1007/s11899-015-0281-2
- By:
- Publication type:
- Article
8
Novel Induction Regimens in Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 388, doi. 10.1007/s11899-015-0282-1
- By:
- Publication type:
- Article
9
Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 395, doi. 10.1007/s11899-015-0283-0
- By:
- Publication type:
- Article
10
Immunological Consequences of JAK Inhibition: Friend or Foe?
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 370, doi. 10.1007/s11899-015-0284-z
- By:
- Publication type:
- Article
11
What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice?
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 380, doi. 10.1007/s11899-015-0285-y
- By:
- Publication type:
- Article
12
Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 405, doi. 10.1007/s11899-015-0286-x
- By:
- Publication type:
- Article
13
Social Media and Myeloproliferative Neoplasms (MPN)-Focus on Twitter and the Development of a Disease-specific Community: #MPNSM.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 413, doi. 10.1007/s11899-015-0287-9
- By:
- Publication type:
- Article
14
Mature T-cell leukemias: Molecular and Clinical Aspects.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 421, doi. 10.1007/s11899-015-0288-8
- By:
- Publication type:
- Article
15
The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 456, doi. 10.1007/s11899-015-0292-z
- By:
- Publication type:
- Article
16
Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 468, doi. 10.1007/s11899-015-0293-y
- By:
- Publication type:
- Article